Hopefulness among individuals living with schizophrenia and their caregivers in Tanzania: an actor-partner interdependence model.
Actor-partner interdependence model (APIM)
Caregiving
Hopefulness
Psychotic disorders
Schizophrenia
Journal
BMC psychiatry
ISSN: 1471-244X
Titre abrégé: BMC Psychiatry
Pays: England
ID NLM: 100968559
Informations de publication
Date de publication:
13 07 2023
13 07 2023
Historique:
received:
25
10
2022
accepted:
30
06
2023
medline:
17
7
2023
pubmed:
14
7
2023
entrez:
13
7
2023
Statut:
epublish
Résumé
Hopefulness is a positive orientation or state of mind that can aid in the recovery and treatment of mental illness, as it can have significant impacts on clinical and psychosocial outcomes. As resource-constrained settings work to implement recovery-oriented care, there is a need to better understand hopefulness among people living with schizophrenia (PLWS) and caregivers in their extended family networks. This study seeks to examine the dyadic relationship of hopefulness and its associated correlates among PLWS attending outpatient psychiatric clinics and their caregivers in Tanzania. This study utilized baseline and immediate post-intervention data collected as part of a randomized controlled trial testing a culturally tailored model of Family Psychoeducation, KUPAA, in Tanzania. The Herth Hope Index was used to measure hopefulness among PLWS (n = 33) and their caregivers (n = 33) at baseline and immediate post-intervention. Univariable and multivariable regression models were conducted to determine correlates of hopefulness at baseline, while the Actor-Partner Interdependence Model (APIM) was employed to examine the longitudinal, dyadic relationship of hopefulness among and between PLWS and their caregivers. Better family functioning was associated with higher levels of hopefulness in PLWS and their caregivers. Lower levels of stigma, lower symptom severity, and lower disability were associated with higher levels of hopefulness in PLWS. For PLWS and their caregivers, actor effects from the APIM model were less than one (PLWS, [Formula: see text]; caregivers, [Formula: see text]), indicating stability (within each person) in hopefulness over time. Regarding partner effects, a caregiver's baseline hopefulness had a positive effect on the hopefulness of their PLWS at follow-up ([Formula: see text]). This indicates that higher caregiver hope at time 0 is associated with higher levels of hope in PLWS at time 1. Baseline hopefulness levels for PLWS had a negative effect on caregivers' hopefulness at follow-up ([Formula: see text]). This suggests that higher hopefulness among PLWS at baseline is associated with lower levels of hope in caregivers at follow-up. Hopefulness is important to consider in family or caregiver-based treatments for PLWS because caregiver hopefulness may influence improvements in hopefulness among PLWS over time. Future studies should further explore the longitudinal dyadic relationship of hopefulness for these populations, as hope is a non-pharmacological and modifiable mechanism of change that is underutilized in care and treatment plans for PLWS globally. Clinical Trials #NCT04013932, July 10, 2019.
Sections du résumé
BACKGROUND
Hopefulness is a positive orientation or state of mind that can aid in the recovery and treatment of mental illness, as it can have significant impacts on clinical and psychosocial outcomes. As resource-constrained settings work to implement recovery-oriented care, there is a need to better understand hopefulness among people living with schizophrenia (PLWS) and caregivers in their extended family networks. This study seeks to examine the dyadic relationship of hopefulness and its associated correlates among PLWS attending outpatient psychiatric clinics and their caregivers in Tanzania.
METHODS
This study utilized baseline and immediate post-intervention data collected as part of a randomized controlled trial testing a culturally tailored model of Family Psychoeducation, KUPAA, in Tanzania. The Herth Hope Index was used to measure hopefulness among PLWS (n = 33) and their caregivers (n = 33) at baseline and immediate post-intervention. Univariable and multivariable regression models were conducted to determine correlates of hopefulness at baseline, while the Actor-Partner Interdependence Model (APIM) was employed to examine the longitudinal, dyadic relationship of hopefulness among and between PLWS and their caregivers.
RESULTS
Better family functioning was associated with higher levels of hopefulness in PLWS and their caregivers. Lower levels of stigma, lower symptom severity, and lower disability were associated with higher levels of hopefulness in PLWS. For PLWS and their caregivers, actor effects from the APIM model were less than one (PLWS, [Formula: see text]; caregivers, [Formula: see text]), indicating stability (within each person) in hopefulness over time. Regarding partner effects, a caregiver's baseline hopefulness had a positive effect on the hopefulness of their PLWS at follow-up ([Formula: see text]). This indicates that higher caregiver hope at time 0 is associated with higher levels of hope in PLWS at time 1. Baseline hopefulness levels for PLWS had a negative effect on caregivers' hopefulness at follow-up ([Formula: see text]). This suggests that higher hopefulness among PLWS at baseline is associated with lower levels of hope in caregivers at follow-up.
CONCLUSION
Hopefulness is important to consider in family or caregiver-based treatments for PLWS because caregiver hopefulness may influence improvements in hopefulness among PLWS over time. Future studies should further explore the longitudinal dyadic relationship of hopefulness for these populations, as hope is a non-pharmacological and modifiable mechanism of change that is underutilized in care and treatment plans for PLWS globally.
TRIAL REGISTRATION
Clinical Trials #NCT04013932, July 10, 2019.
Identifiants
pubmed: 37442999
doi: 10.1186/s12888-023-04990-8
pii: 10.1186/s12888-023-04990-8
pmc: PMC10339619
doi:
Banques de données
ClinicalTrials.gov
['NCT04013932']
Types de publication
Randomized Controlled Trial
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
508Subventions
Organisme : NIMH NIH HHS
ID : R34 MH106663
Pays : United States
Informations de copyright
© 2023. The Author(s).
Références
Appl Nurs Res. 2017 Apr;34:7-11
pubmed: 28342628
Neuropsychiatr Dis Treat. 2017 Feb 23;13:567-576
pubmed: 28260904
PLoS Med. 2009 Oct;6(10):e1000165
pubmed: 19841735
Schizophr Bull. 1995;21(4):631-43
pubmed: 8749890
Rev Bras Enferm. 2022 Feb 25;75Suppl 3(Suppl 3):e20210474
pubmed: 35239861
Schizophr Bull. 2019 Mar 7;45(2):277-283
pubmed: 29939361
Cochrane Database Syst Rev. 2011 Jun 15;(6):CD002831
pubmed: 21678337
BMC Psychiatry. 2022 Jan 4;22(1):10
pubmed: 34983438
Indian J Psychiatry. 2017 Oct-Dec;59(4):420-428
pubmed: 29497183
SAGE Open Nurs. 2019 May 8;5:2377960819844381
pubmed: 33415238
Int J Environ Res Public Health. 2021 Mar 02;18(5):
pubmed: 33801391
Cult Health Sex. 2015;17(6):718-32
pubmed: 25597368
J Adv Nurs. 1992 Oct;17(10):1251-9
pubmed: 1430629
Curr Psychiatry Rep. 2017 Jan;19(1):2
pubmed: 28097634
Psychiatry Res. 2015 Aug 30;228(3):272-6
pubmed: 26165962
BMC Psychol. 2020 Jan 29;8(1):5
pubmed: 31996246
Hu Li Za Zhi. 2019 Aug;66(4):29-39
pubmed: 31342499
Arch Psychiatr Nurs. 2017 Aug;31(4):332-337
pubmed: 28693867
Psychiatr Q. 2020 Sep;91(3):877-886
pubmed: 32361795
J Fam Psychol. 2017 Aug;31(5):592-603
pubmed: 28240919
Lancet Psychiatry. 2019 May;6(5):365-367
pubmed: 30954478
Front Psychol. 2017 Jan 04;7:2022
pubmed: 28101071
Schizophr Bull. 1987;13(2):261-76
pubmed: 3616518
J Int Assoc Provid AIDS Care. 2017 Mar/Apr;16(2):140-148
pubmed: 24963087
J Rehabil Res Dev. 2008;45(6):911-9
pubmed: 19009477
Community Ment Health J. 2019 Jan;55(1):42-50
pubmed: 30506465
Soc Psychiatry Psychiatr Epidemiol. 2019 Jul;54(7):861-870
pubmed: 30603806
Schizophr Bull. 2018 Oct 17;44(6):1195-1203
pubmed: 29762765
Psychiatr Q. 2019 Sep;90(3):579-586
pubmed: 31154551
BMC Psychiatry. 2016 May 14;16:146
pubmed: 27177934
Psychiatr Rehabil J. 2019 Jun;42(2):139-146
pubmed: 30556725
J Psychiatr Ment Health Nurs. 2006 Dec;13(6):651-64
pubmed: 17087667
Lancet Psychiatry. 2021 Nov;8(11):969-980
pubmed: 34653393
Psychiatry Res. 2003 Nov 1;121(1):31-49
pubmed: 14572622
Neuro Endocrinol Lett. 2018 Mar;39(1):9-18
pubmed: 29604619